Blog

Archive for the ‘Jim’s Stock Alerts’ Category

Sort alerts by: Date | Company Name
SolarEdge Technologies (SEDG)

SolarEdge rockets 17.94% today on analyst upgrades ahead of earnings today after the close

SolarEdge Technologies (SEDG) closed up 17.94% today ahead of fourth quarter earnings due after the close. Cascend Securities raised its target price on the shares by 17% during today's session. Today's jump will, of course, make it harder for the company to beat expectations with today's earnings report. The stock is already up 28.1% in […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Microsoft (MSFT)

I will be selling Microsoft out of my Dividend Portfolio on Friday, February 21

When I revised my Dividend Portfolio back on November 11, 2019, the idea was to add a few stocks that paid very low dividend yields now but that showed a likelihood of raising dividends substantially in the coming years. That way, you'd be buying future higher yields at a reduced current price. One of those […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Apple (AAPL)

Apple says it won’t make revenue guidance for the quarter that ends in March

Breaking news: Today Apple said it won't meet revenue guidance for the March quarter due to work slowdowns and lower demand due to the outbreak of the coronavirus in China. In it guidance for the quarter, issued on January 28, Apple had given an larger than usual range for revenue in the March quarter due to […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Intrexon (XON)

Still selling Intrexon (now Precigen) even though the 293% gain yesterday wasn’t real

Frankly, my first reaction was to think it was a misprint, especially because while the ticker still read XON, the name of the attached stock had changed from Intrexon to Precigen. And it was. A misprint, that is. The print yesterday showed that the stock, a member of my Volatility Portfolio since November 9, 2018, had […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Barrick Gold (GOLD)

Raising target on Barrick Gold in Jubak Picks Portfolio and buying the shares for my Dividend Portfolio

Barrick Gold (GOLD) reported fourth quarter earnings of 17 cents a share on Wednesday, February 12. That beat the 14 cents a share estimate from Wall Street analysts for the quarter. A year ago the company earned 6 cents a share in the fourth quarter of 2018. But that wasn't the BIG surprise from the […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Precigen (XON)

Selling Intrexon (now Precigen) after 293% gain today

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

AbbVie (ABBV)

AbbVie continues its run–picks up momentum from Allergan results

Shares of AbbVie (ABBV) tacked on another 1.32% today to a close at $96 continuing a run that began back on January 31 at $81.02. The trend picked up momentum on February 7 after the company reported fourth quarter earnings with better than expected sales for its blockbuster Humira drug that has picked up competition […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Barrick Gold (GOLD)

Gold is climbing while VIX falls and stocks set new records? But why?

Gold is supposed to go up when investors and traders are looking for safe havens and hedges against market volatility. So it makes sense the gold and gold mining stocks are gaining as coronavirus stalks through the land. Gold closed up 0.99% today to $1570.50 an ounce. But the financial markets don't seem to be […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Beyond Meat (BYND)

Another piece in the Beyond Meat puzzle

I'm trying to figure out the puzzle that is Beyond Meat (BYND), the only publicly traded plant-based meat stock. Is plant-based meat a revolutionary, category shattering food product? In which case shares of Beyond Meat are an absolute bargain even at $110.43 a share (as of the close on February 4) and a market cap […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.

Albemarle (ALB)

Albemarle, other lithium stocks, ride Tesla’s draft

Shares of electric car maker Tesla (TSLA) were up another 21.6% as of 3:15 p.m. New York time to another all-time high. And shares of lithium miners, who produce the stuff that goes into Tesla batteries, rode the draft higher with Albemarle (ALB) picking up 12.27% and SQM (SQM) gaining 9.76%. Albemarle is a member of […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.